PPARD
PPARD (peroxisome proliferator activated receptor delta, also known as PPARB, NR1C2, NUC1, NUCII and FAAR) is a ligand-activated transcription factor of the nuclear hormone receptor family. It binds fatty acids and peroxisome proliferators and acts as a key mediator of energy metabolism in adipose tissues. Browse Assay Genie's current range of PPARD research reagents below, or read on for the biology behind the target.
PPARD is a receptor that binds peroxisome proliferators, including hypolipidemic drugs and fatty acids, and shows a preference for poly-unsaturated fatty acids such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of its target genes. In this way it regulates the peroxisomal beta-oxidation pathway of fatty acids, and it functions as a transcription activator for the acyl-CoA oxidase gene. Ligand-activated PPARD also decreases expression of NPC1L1.
The PPARD gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) family, which belongs to the nuclear hormone receptor family and its NR1 subfamily. The protein localises to the nucleus. It is thought to act as an integrator of transcriptional repression and nuclear receptor signalling, and it may inhibit the ligand-induced transcriptional activity of PPAR alpha and PPAR gamma, although the evidence for this effect is inconsistent. Alternative splicing gives multiple transcript variants that encode distinct protein isoforms.
Knockout studies in mice (Ppard) suggest roles for the protein in myelination of the corpus callosum, lipid metabolism, differentiation and epidermal cell proliferation. In colorectal cancer cells, expression of the gene may be variable but is typically relatively low. The gene has appeared in the literature under several names, including peroxisome proliferative activated receptor, delta, as well as the symbols NR1C2, PPARB, NUC1, NUCII and FAAR.
PPARD is a key mediator of energy metabolism in adipose tissues, making it a central target for studies of fatty acid handling.
The receptor regulates the peroxisomal beta-oxidation pathway and activates transcription of the acyl-CoA oxidase gene.
PPARD may integrate transcriptional repression with nuclear receptor signalling and may modulate PPAR alpha and PPAR gamma activity.
Mouse knockout studies point to roles in myelination, differentiation and epidermal proliferation, and PPARD expression in colorectal cancer cells is typically low.
PPARD is a ligand-activated transcription factor that binds fatty acids and peroxisome proliferators. Once activated, it binds promoter elements of target genes, regulates peroxisomal beta-oxidation of fatty acids, activates the acyl-CoA oxidase gene and decreases NPC1L1 expression. It is a key mediator of energy metabolism in adipose tissues.
PPARD is also called PPARB, NR1C2, NUC1, NUCII and FAAR, and was previously named peroxisome proliferative activated receptor, delta. Alternative splicing produces multiple transcript variants that encode distinct protein isoforms, so check the datasheet of any product for its validated reactivity.
The mouse ortholog is Ppard. Knockout studies in mice suggested roles in myelination of the corpus callosum, lipid metabolism, differentiation and epidermal cell proliferation. Check the datasheet of any product for its validated reactivity before using it in mouse samples.
Other PPAR family members and lipid-metabolism targets linked to PPARD signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q03181; product specifications from Assay Genie datasheets.